PGLYRP3

mutation — cross-omics
Cross-omicsMUTATION → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, PGLYRP3 mutation is significantly associated with the RNA expression of many other genes, with 635 significant associations in total. UCEC shows the largest number of these associations.

The most reproducible PGLYRP3-associated genes across cancer lineages are TRAJ46, LRRC6P1, and NAGPA-AS1. Each is linked with PGLYRP3 in more than 2 cancer types. Because this analysis shows association rather than direction, both PGLYRP3-to-partner and partner-to-PGLYRP3 results are reported.

Each partner links to its own Q-omics profile. The box plot shows the strongest example, TRAJ46 grouped by PGLYRP3-low versus PGLYRP3-high in SARC.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (PGLYRP3→partner) and Y-score (partner→PGLYRP3) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
SARCTRAJ46 →+0.974+5.224<.001.00633
LIHCLRRC6P1 →+0.052+6.902<.001<.00132
LIHCNAGPA-AS1 →+0.079+6.008<.001.00232
SKCMHYKK →+0.383+2.019.001.00132
SKCMRNU1-49P →+0.114+3.119<.001.00432
SKCMRN7SL300P →+0.115+1.881<.001.00132
Each partner links to its Q-omics profile. Showing the 6 strongest of 635 associations by consensus.

TRAJ46 by PGLYRP3 expression — SARC

Box plot of TRAJ46 in PGLYRP3-low vs PGLYRP3-high samples in SARC.

Explore this box plot interactively →

Exploration